Boundless Bio: Funding, Investors & Team (Oct 2026)
Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers. Boundless Bio was founded in 2018 and is headquartered in La Jolla, California.
Boundless Bio has raised $205M across 2 funding rounds on record, the most recent a Series C of $100M announced in May 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Boundless Bio Company Profile and Key Stats
Latest funding round on record: May 2023.
Boundless Bio Funding Rounds
Boundless Bio raised $105M in a Series B announced in Apr 2021.
2.1 years later, a Series C of $100M was announced in May 2023.
Boundless Bio Founders and Leadership Team
Contact details for the Boundless Bio team: 1 of 2 have an email address on file.
Start 14-day free trial →Boundless Bio Funding Compared to Other Biotechnology Startups
Boundless Bio's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Boundless Bio in Biotechnology and La Jolla
Companies Similar to Boundless Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Boundless Bio Funding FAQs
What does Boundless Bio do?
Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers. Boundless Bio was founded in 2018 and is headquartered in La Jolla, California.
How much funding has Boundless Bio raised?
Boundless Bio has raised $205M across 2 rounds on record. The most recent is a Series C of $100M announced in May 2023.
When did Boundless Bio last raise funding?
Boundless Bio's most recent funding round on record is a Series C of $100M, announced in May 2023.
Who founded Boundless Bio?
FundedIQ lists Benjamin Cravatt (Founder) at Boundless Bio.
Who is the CEO of Boundless Bio?
Zachary Hornby is listed as CEO at Boundless Bio.
Where is Boundless Bio headquartered?
Boundless Bio is based in La Jolla, California, United States.
How many employees does Boundless Bio have?
Boundless Bio is in the 11-50 employee band.
How does Boundless Bio's funding compare to other Biotechnology startups?
Boundless Bio's latest round of $100M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Boundless Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Boundless Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.